2 citations · 2 across the 2 of their papers we have counts for
2 papers
q-bio.BM2026
Latent-Y: A Lab-Validated Autonomous Agent for De Novo Drug Design
Latent Labs Team, Sebastian M. Schmon, Daniella Pretorius +17
Drug discovery relies on iterative expert workflows that are slow to parallelize and difficult to scale. Here we introduce Latent-Y, an AI agent that autonomously executes complete…
q-bio.BM2025★ 2 cited
Drug-like antibodies with low immunogenicity in human panels designed with Latent-X2
Latent Labs Team, Henry Kenlay, Daniella Pretorius +15
Drug discovery has long sought computational systems capable of designing drug-like molecules directly: developable and non-immunogenic from the start. Here we introduce Latent-X2,…